These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic spectrum in the treatment of myelodysplastic syndromes. Hofmann WK; Baldus C; Uharek L; Thiel E Expert Opin Pharmacother; 2004 Dec; 5(12):2451-8. PubMed ID: 15571463 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of MDS]. Usuki K Rinsho Ketsueki; 2014 Oct; 55(10):1882-92. PubMed ID: 25297752 [No Abstract] [Full Text] [Related]
5. Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone? Musto P; Falcone A; Carotenuto M; Catalano L; Cennamo A; Rotoli B Blood; 1994 Sep; 84(5):1687-8. PubMed ID: 7520783 [No Abstract] [Full Text] [Related]
9. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes. Schultz AB; Geller RB; Hillyer CD J Hematother; 1995 Aug; 4(4):323-34. PubMed ID: 7489147 [No Abstract] [Full Text] [Related]
10. [The myelodysplastic syndrome II. New therapeutic principles, course and prognosis]. Hasselbalch HC; Juhl BR; Hansen PB Ugeskr Laeger; 2002 Jan; 164(4):479-82. PubMed ID: 11838418 [TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome. Hofmann WK; Koeffler HP Annu Rev Med; 2005; 56():1-16. PubMed ID: 15660498 [TBL] [Abstract][Full Text] [Related]
12. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda". Molteni A; Riva M; Pellizzari A; Borin L; Freyrie A; Greco R; Ubezio M; Bernardi M; Fariciotti A; Nador G; Nichelatti M; Ravano E; Morra E Leuk Res; 2013 Oct; 37(10):1233-40. PubMed ID: 23906627 [TBL] [Abstract][Full Text] [Related]
14. [The strategy for the treatment of myelodysplastic syndromes]. Hideaki M Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745 [No Abstract] [Full Text] [Related]
15. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors. Shibuya A; Ishii S; Obinata K Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817 [TBL] [Abstract][Full Text] [Related]
16. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes. Malcovati L Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858 [TBL] [Abstract][Full Text] [Related]